01-07-2025 08:21 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Share Holdings
Mankind Pharma Ltd.
 
BSE Code 543904
ISIN Demat INE634S01028
Book Value 354.72
NSE Code MANKIND
Dividend Yield % 0.00
Market Cap 958686.34
P/E 50.88
EPS 45.65
Face Value 1  
Description ( As On March 2025 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter  13  299960612  72.7  299960612  
  Foreign Promoter          
  Total Promoter  13  299960612  72.7  299960612  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI  32  31642919  7.67  31642919  
  FI/Bank/Insurance  11  9201958  2.23    
  Govt  1  3013    3013  
  FII          
  Other  595  59679297  14.47  59679297  
  Total Institutions  639  100527187  24.37  100527187  
 Non-Institution          
  Bodies Corporate  768  4580019  1.11  4580019  
  Individuals          
  NRIs/OCBs  2910  298542  0.07  298542  
  Others  176267  7212167  1.75  7212167  
  Total Non-Institution  179945  12090728  2.93  12090728  
Total Non Promoter  180584  112617915  27.3  112617915  
          
  Depository Receipts          
          
Grand Total  180597  412578527  100  412578527  
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.